Compare IPSC & CBAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | IPSC | CBAN |
|---|---|---|
| Founded | 2019 | 1975 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 362.5M | 423.6M |
| IPO Year | 2021 | 1995 |
| Metric | IPSC | CBAN |
|---|---|---|
| Price | $1.93 | $22.21 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $4.25 | N/A |
| AVG Volume (30 Days) | ★ 662.1K | 208.5K |
| Earning Date | 05-11-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 2.44% |
| EPS Growth | ★ 91.30 | 16.91 |
| EPS | N/A | ★ 0.90 |
| Revenue | ★ $109,164,000.00 | N/A |
| Revenue This Year | N/A | $35.41 |
| Revenue Next Year | N/A | $4.84 |
| P/E Ratio | ★ N/A | $24.46 |
| Revenue Growth | ★ 1556.76 | N/A |
| 52 Week Low | $0.44 | $15.80 |
| 52 Week High | $2.97 | $22.40 |
| Indicator | IPSC | CBAN |
|---|---|---|
| Relative Strength Index (RSI) | 40.80 | 63.76 |
| Support Level | $1.90 | $19.20 |
| Resistance Level | $2.62 | $22.40 |
| Average True Range (ATR) | 0.12 | 0.39 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 13.64 | 83.07 |
Century Therapeutics Inc is a biotechnology company harnessing the power of allogeneic pluripotent stem cell therapies to develop potentially curative cell therapy products for autoimmune diseases, including type 1 diabetes, or T1D, and cancer. Its beta islet, T cell and NK cell programs are allogeneic, meaning it is derived from healthy donors for use in any patient, rather than being sourced from an individual for their own specific use, as is the case with autologous T cells. The cell types it can generate from iPSCs, including iPSC-derived beta islet cells, iPSC-derived CD4+ and CD8+ alphabeta T cells, or alphabeta iT cells, and iPSC- natural killer cells, or iNK cells.
Colony Bankcorp Inc is a bank holding company. The bank provides a broad range of banking services to its retail and commercial customers. Its product line includes loans to small and medium-sized businesses, residential and commercial construction and land development loans, commercial real estate loans, agri-business and production loans, residential mortgage loans, consumer loans, and a variety of demand, savings, and time deposit products. The company's segments include the Banking Division, Retail Mortgage Division and small business specialty lending divisions. It generates maximum revenue from the Banking Division.